Answers are grounded in this paper and cite their sources.
Background Intramuscular ozone is used in musculoskeletal practice, but local skeletal-muscle responses to different concentrations and administration frequencies remain incompletely characterized. Methods A total of 124 male Sprague–Dawley rats were studied in two stages. The screen included 80 rats assigned to 16 groups and 15 ozone regimens (20–60 µg/mL; 1, 2, or 7 injections/week) for 2 weeks. A separate cohort of 44 rats compared saline control, 30 µg/mL twice weekly (LD-OZ), 60 µg/mL twice weekly (HD-OZ), and 30 µg/mL seven times weekly (HF-OZ) for up to 7 weeks. Endpoints were assessed at prespecified times using endpoint-specific sampling schedules. Results In the screen, the quadriceps-to-body-weight ratio averaged 97.1%, 96.8%, and 90.4% of control at 1, 2, and 7 injections/week, respectively; frequency had a significant effect, whereas concentration and interaction did not. LD-OZ was associated with 11% higher grip strength, 71% higher ATP, and 107% higher succinate dehydrogenase activity at week 1. HD-OZ and HF-OZ were associated with 17% and 26% lower grip strength and approximately 40% and 50% lower fibre cross-sectional area. Higher-exposure regimens were also associated with redox changes, inflammatory and NLRP3–GSDMD-related markers, and proteolysis-related changes; collagen area was most clearly increased in HF-OZ. Gross muscle mass did not detect the HD-OZ phenotype. Conclusions The findings support a regimen- and endpoint-dependent response pattern compatible with, but not proof of, hormesis-like behaviour. Frequency-matched procedural controls, intermediate regimens, and pathway-directed experiments are needed to clarify specificity and mechanism.
No takes yet. Share an insight, caveat, or question.
Liu¹ et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: